PP
TARA icon

Paloma Partners’s Protara Therapeutics TARA Stock Holding History

Paloma Partners’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-728
Closed -$234K – 2121
2016
Q2 		$234K Buy
+728
New +$218K ﹤0.01% 1883

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Paloma Partners's TARA Position: Q3 2016 in Review

Paloma Partners sold out of Protara Therapeutics (TARA) in Q3 2016, closing a stake of 728 shares — an estimated $234K sold.

Paloma Partners first reported a position in TARA in Q2 2016 and held it in 1 quarter. The position peaked at $234K in Q2 2016. 29 funds tracked by Wall St. Rank hold TARA as of Q3 2016.

  • Paloma Partners reported no remaining Protara Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Paloma Partners sold 728 Protara Therapeutics shares in Q3 2016, an estimated $234K.
  • Paloma Partners first reported a position in Protara Therapeutics in Q2 2016 and held it in 1 quarter.
  • Paloma Partners's Protara Therapeutics position peaked at $234K in Q2 2016.
  • 29 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2016.

Based on Paloma Partners's 13F filing for Q3 2016, filed 14 Nov 2016.